The FDA Issues Draft Guidance for Non-Opioid Chronic Pain Products – It Has Been an Arduous Quest for Industry!
The opioid crisis continues, and the battle of addiction remains ongoing as well. The FDA has approved one new non-opioid pain reliever (Journavx (suzetrigine tablets)) for moderate to severe acute pain in adults. The application holder UC Health claims (here) “[T]his new oral painkiller — the first approved by the FDA in more than 20 […]

